Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Inoue

Showing results (321-330 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Medicine|May 14, 2022
Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective StudyJun Inoue, Tomoo Kobayashi, Takehiro Akahane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 25, 2023
Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patientsJun Inoue, Takehiro Akahane, Tomoo Kobayashi, et al.
Journal of Viral Hepatitis|March 7, 2025
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide AnaloguesJun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
Journal of Gastroenterology|January 27, 2026
Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in JapanMasatsugu Ohara, Ritsuzo Kozuka, Yoshihito Uchida, et al.
Scientific Reports|September 1, 2025
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled studyEri Tokunaga, Jun Inoue, Naoki Asaji, et al.
Cancer Medicine|October 15, 2025
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced StageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Pancreas|October 27, 2023
Metabolic Syndrome Accelerates the Age-Related Increase of Intraductal Papillary Mucinous Neoplasm of the PancreasShunta Tanaka, Masahiro Tsujimae, Atsuhiro Masuda, et al.
Scientific Reports|November 25, 2023
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Journal of Gastroenterology|September 29, 2022
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in JapanKazumasa Sakamoto, Kiyoaki Ito, Hiroshi Yotsuyanagi, et al.
Annals of Surgical Oncology|May 23, 2022
Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous NeoplasmMasahiro Tsujimae, Atsuhiro Masuda, Takuya Ikegawa, et al.
Pageof 34

Showing results (321-330 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Medicine|May 14, 2022
Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective StudyJun Inoue, Tomoo Kobayashi, Takehiro Akahane, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 25, 2023
Usefulness of the Fibrosis-4 index and alanine aminotransferase at 1 year of nucleos(t)ide analog treatment for prediction of hepatocellular carcinoma in chronic hepatitis B patientsJun Inoue, Takehiro Akahane, Tomoo Kobayashi, et al.
Journal of Viral Hepatitis|March 7, 2025
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide AnaloguesJun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
Journal of Gastroenterology|January 27, 2026
Continuity of long-term follow-up in patients with chronic hepatitis C after sustained virologic response following direct-acting antiviral therapy: a nationwide real-world multicenter cohort study in JapanMasatsugu Ohara, Ritsuzo Kozuka, Yoshihito Uchida, et al.
Scientific Reports|September 1, 2025
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled studyEri Tokunaga, Jun Inoue, Naoki Asaji, et al.
Cancer Medicine|October 15, 2025
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced StageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Pancreas|October 27, 2023
Metabolic Syndrome Accelerates the Age-Related Increase of Intraductal Papillary Mucinous Neoplasm of the PancreasShunta Tanaka, Masahiro Tsujimae, Atsuhiro Masuda, et al.
Scientific Reports|November 25, 2023
A new model to estimate duration of survival in patients with hepatocellular carcinoma with BCLC intermediate stageMasashi Ninomiya, Mio Tsuruoka, Jun Inoue, et al.
Journal of Gastroenterology|September 29, 2022
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in JapanKazumasa Sakamoto, Kiyoaki Ito, Hiroshi Yotsuyanagi, et al.
Annals of Surgical Oncology|May 23, 2022
Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous NeoplasmMasahiro Tsujimae, Atsuhiro Masuda, Takuya Ikegawa, et al.
Pageof 34